Application 203312

Type
NDA
Sponsor
IMPAX LABS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001RYTARYCARBIDOPA; LEVODOPACAPSULE, EXTENDED RELEASE;ORAL23.75MG;95MGYesNo
002RYTARYCARBIDOPA; LEVODOPACAPSULE, EXTENDED RELEASE;ORAL36.25MG;145MGYesNo
003RYTARYCARBIDOPA; LEVODOPACAPSULE, EXTENDED RELEASE;ORAL48.75MG;195MGYesNo
004RYTARYCARBIDOPA; LEVODOPACAPSULE, EXTENDED RELEASE;ORAL61.25MG;245MGYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
64896-661RYTARYLevodopa and CarbidopaAmneal Pharmaceuticals LLCNDACurrent
64896-661RYTARYLevodopa and CarbidopaAmneal Pharmaceuticals LLCNDACurrent
64896-661RYTARYLevodopa and CarbidopaAmneal Pharmaceuticals LLCNDACurrent
64896-661RYTARYLevodopa and CarbidopaImpax Specialty PharmaNDACurrent
64896-661RYTARYLevodopa and CarbidopaAmneal Pharmaceuticals LLCNDACurrent
64896-662RYTARYLevodopa and CarbidopaAmneal Pharmaceuticals LLCNDACurrent
64896-662RYTARYLevodopa and CarbidopaAmneal Pharmaceuticals LLCNDACurrent
64896-662RYTARYLevodopa and CarbidopaAmneal Pharmaceuticals LLCNDACurrent
64896-662RYTARYLevodopa and CarbidopaAmneal Pharmaceuticals LLCNDACurrent
64896-662RYTARYLevodopa and CarbidopaImpax Specialty PharmaNDACurrent
64896-663RYTARYLevodopa and CarbidopaAmneal Pharmaceuticals LLCNDACurrent
64896-663RYTARYLevodopa and CarbidopaImpax Specialty PharmaNDACurrent
64896-663RYTARYLevodopa and CarbidopaAmneal Pharmaceuticals LLCNDACurrent
64896-663RYTARYLevodopa and CarbidopaAmneal Pharmaceuticals LLCNDACurrent
64896-663RYTARYLevodopa and CarbidopaAmneal Pharmaceuticals LLCNDACurrent
64896-664RYTARYLevodopa and CarbidopaAmneal Pharmaceuticals LLCNDACurrent
64896-664RYTARYLevodopa and CarbidopaAmneal Pharmaceuticals LLCNDACurrent
64896-664RYTARYLevodopa and CarbidopaAmneal Pharmaceuticals LLCNDACurrent
64896-664RYTARYLevodopa and CarbidopaAmneal Pharmaceuticals LLCNDACurrent
64896-664RYTARYLevodopa and CarbidopaImpax Specialty PharmaNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85496SUPPL 2026-03-24
85448SUPPL 2026-03-23
61362SUPPL2019-12-20
61328SUPPL2019-12-18
48468SUPPL2017-05-19
45733SUPPL2016-10-31
44881ORIG2016-06-15
43426ORIG2016-06-15
40286ORIG2015-01-08
32407ORIG2015-01-08